Benign breast disease.
Mauvais-Jarvis
P
P
Necker School of Medicine, Descartes University, Paris, France.
Kuttenn
F
F
D000328:Adult; D001941:Breast Diseases / Q000145:classification / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use*; D003613:Danazol / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D018226:Fibroadenoma / Q000188:drug therapy; D005348:Fibrocystic Breast Disease / Q000188:drug therapy; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D017697:Premenopause; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use*; D011388:Prolactin / Q000037:antagonists & inhibitors
D004965:Estrogen Antagonists; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D011374:Progesterone; D011388:Prolactin; D003613:Danazol